A blood test for depression?
07-26-2010: Blood tests have been extremely important tools aiding doctors in making medical diagnoses and in guiding the treatment of many diseases. However, psychiatry is one area of medicine where there are few diagnostic blood tests.
New scientific fields may someday generate blood tests that can be used for these purposes. Some of the areas under increasingly intensive study are genetics, the study of variations in the genes (DNA) that can be extracted from blood cells, and genomics like proteomics, the measurement of the levels of specific proteins in the blood, and gene expression profiling, which measures the levels of RNA produced from DNA as an indication of the level of the "activity" of particular genes.
Using the latter approach, Dutch researchers evaluated blood gene expression profiles in healthy individuals and patients diagnosed with major depressive disorder, or MDD. They identified a set of seven genes in whole blood that was able to distinguish un-medicated MDD patients from healthy controls.
"This is a first, but major step in providing a molecular diagnostic tool for depression," explained Dr. Sabine Spijker, corresponding author of this study. Although psychiatry already has specific criteria for diagnosing mental health disorders, this type of diagnosis would be unbiased and particularly valuable for those with whom it is more difficult to have a conversation. It may also eventually assist in reducing the stigma associated with mental health problems.
"It is far too early to be confident that gene expression profiling will lead us to diagnostic or prognostic tests for depression. However, the objective of this line of research is extremely important," cautions Dr. John Krystal, Editor of Biological Psychiatry. "In the past, many types of tests have been explored as potential diagnostic markers, but they all have failed to have sufficient sensitivity and specificity to guide doctors in making psychiatric diagnoses or choosing between treatments. I look forward to seeing whether the patterns of gene expression profiling are replicable and diagnostically specific as multiple groups report their findings."
Most importantly, the authors hope that this study is a stepping stone for finding markers that might predict treatment outcome and recurrence.
Original publication: Sabine Spijker et al.; "Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder"; Biological Psychiatry, Volume 68, Issue 2 (July 15, 2010)
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
- Capsule that can target prostate cancer -
- Agilent Technologies and Mississippi State University Team Up to Test Gulf Seafood for Oil Contamination -
- Epigenomics: Licensee ARUP Laboratories Launches Septin9 Colorectal Cancer Blood Test in the United States -
- SGE Analytical Science: eVol Wins prestigious R&D100 Technology Innovation Award -
- Novasep and instrAction enter a worldwide strategic alliance for non-chiral chromatography -





